Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study

OBJECTIVE: The most severe complication associated with giant coronary aneurysm in children with Kawasaki disease is ischemic cardiomyopathy (ICM) caused by thrombosis. Addition of tissue plasminogen activator, Alteplase, in the treatment regimen can be an efficient thrombolytic therapy, and therefo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Yanqiu, Xu, Yunming, Wang, Ce, Yu, Xiaona, Ma, Quanmei, Wang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720999/
https://www.ncbi.nlm.nih.gov/pubmed/36471358
http://dx.doi.org/10.1186/s12969-022-00767-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720999/
https://www.ncbi.nlm.nih.gov/pubmed/36471358
http://dx.doi.org/10.1186/s12969-022-00767-7

Ejemplares similares